Formycon AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.76 |
Market Cap |
EUR288.33 M |
Shares Outstanding |
9.42 M |
Public Float |
9.42 M |
Address |
Fraunhoferstraße 15 Munich Bayern (Bavaria) 82152 Germany |
Employees | - |
Website | http://formycon.com |
Updated | 07/08/2019 |
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany. |